Rikke Olesen Department of Clinical Medicine Aarhus University Biography Publications Institution JoVE Articles Rikke Olesen has not added a biography. If you are Rikke Olesen and would like to personalize this page please email our Author Liaison for assistance. Publications Fimepinostat, a Novel Dual Inhibitor of HDAC and PI3K, Effectively Reverses HIV-1 Latency Without T Cell Activation Journal of Virus Eradication. Sep, 2019 | Pubmed ID: 31700656 Fimepinostat, a Novel Dual Inhibitor of HDAC and PI3K, Effectively Reverses HIV-1 Latency Without T Cell Activation Journal of Virus Eradication. Sep, 2019 | Pubmed ID: 31700655 Injury in Yoga Asana Practice: Assessment of the Risks Journal of Bodywork and Movement Therapies. Jul, 2019 | Pubmed ID: 31563359 Effects of Yoga Asana Practice Approach on Types of Benefits Experienced International Journal of Yoga. Sep-Dec, 2019 | Pubmed ID: 31543630 TLR9 Agonist MGN1703 Enhances B Cell Differentiation and Function in Lymph Nodes EBioMedicine. Jul, 2019 | Pubmed ID: 31300344 Effects of 24-week Toll-like Receptor 9 Agonist Treatment in HIV Type 1+ Individuals AIDS (London, England). 07, 2019 | Pubmed ID: 30932955 CAIMP Administration in Humanized Mice Induces a Chimerization-level-dependent STING Response Immunology. 06, 2019 | Pubmed ID: 30919991 Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Lipopolysaccharide-Induced Inflammatory Responses MSphere. Jan-Feb, 2018 | Pubmed ID: 29468194 The TLR9 Agonist MGN1703 Triggers a Potent Type I Interferon Response in the Sigmoid Colon Mucosal Immunology. Mar, 2018 | Pubmed ID: 28766555 Optimizing Recovery of Frozen Human Peripheral Blood Mononuclear Cells for Flow Cytometry PloS One. 2017 | Pubmed ID: 29091947 Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. Jun, 2017 | Pubmed ID: 28329286 Combined Effect of Vacc-4x, Recombinant Human Granulocyte Macrophage Colony-stimulating Factor Vaccination, and Romidepsin on the HIV-1 Reservoir (REDUC): a Single-arm, Phase 1B/2A Trial The Lancet. HIV. 10, 2016 | Pubmed ID: 27658863 Broad Activation of Latent HIV-1 in Vivo Nature Communications. 09, 2016 | Pubmed ID: 27605062 Immune Checkpoints and the HIV-1 Reservoir: Proceed with Caution Journal of Virus Eradication. Jul, 2016 | Pubmed ID: 27482460 ART Influences HIV Persistence in the Female Reproductive Tract and Cervicovaginal Secretions The Journal of Clinical Investigation. Mar, 2016 | Pubmed ID: 26854925 HIV-1 Transcriptional Activity During Frequent Longitudinal Sampling in Aviremic Patients on Antiretroviral Therapy AIDS (London, England). Mar, 2016 | Pubmed ID: 26595541 The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo PLoS Pathogens. Sep, 2015 | Pubmed ID: 26379282 Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline During Latency-Reversing Treatment with Panobinostat Journal of Virology. Oct, 2015 | Pubmed ID: 26223643 Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: a Pilot Study to Assess Effects on the Central Nervous System Open Forum Infectious Diseases. Jan, 2015 | Pubmed ID: 26034779 The Histone Deacetylase Inhibitor Panobinostat Lowers Biomarkers of Cardiovascular Risk and Inflammation in HIV Patients AIDS (London, England). Jun, 2015 | Pubmed ID: 25870990 Panobinostat, a Histone Deacetylase Inhibitor, for Latent-virus Reactivation in HIV-infected Patients on Suppressive Antiretroviral Therapy: a Phase 1/2, Single Group, Clinical Trial The Lancet. HIV. Oct, 2014 | Pubmed ID: 26423811 Human Breast Milk and Antiretrovirals Dramatically Reduce Oral HIV-1 Transmission in BLT Humanized Mice PLoS Pathogens. 2012 | Pubmed ID: 22737068 Generation of HIV Latency in Humanized BLT Mice Journal of Virology. Jan, 2012 | Pubmed ID: 22013053 Interleukin 12B (IL12B) Genetic Variation and Pulmonary Tuberculosis: a Study of Cohorts from The Gambia, Guinea-Bissau, United States and Argentina PloS One. Feb, 2011 | Pubmed ID: 21339808 Immune Reconstitution of the Female Reproductive Tract of Humanized BLT Mice and Their Susceptibility to Human Immunodeficiency Virus Infection Journal of Reproductive Immunology. Mar, 2011 | Pubmed ID: 21256601 Variants in Toll-like Receptors 2 and 9 Influence Susceptibility to Pulmonary Tuberculosis in Caucasians, African-Americans, and West Africans Human Genetics. Jan, 2010 | Pubmed ID: 19771452 Broad-range Real Time PCR and DNA Sequencing for the Diagnosis of Bacterial Meningitis Scandinavian Journal of Infectious Diseases. 2006 | Pubmed ID: 16338835 Humanisierte NOG-Mäuse für intravaginale HIV-Exposition und Behandlung von HIV-Infektionen Anna H. F. Andersen1,2, Stine S. F. Nielsen1,2, Rikke Olesen1,2, Katharina Mack1, Frederik Dagnæs-Hansen3, Niels Uldbjerg1,4, Lars Østergaard1,2, Ole S. Søgaard1,2, Paul W. Denton1,2,5, Martin Tolstrup1,2 1Department of Clinical Medicine, Aarhus University, 2Department of Infectious Diseases, Aarhus University Hospital, 3Department of Biomedicine, Aarhus University, 4Department of Gynecology and Obstetrics, Aarhus University Hospital, 5Department of Biology, University of Nebraska at Omaha JoVE 60723 Immunology and Infection
Humanisierte NOG-Mäuse für intravaginale HIV-Exposition und Behandlung von HIV-Infektionen Anna H. F. Andersen1,2, Stine S. F. Nielsen1,2, Rikke Olesen1,2, Katharina Mack1, Frederik Dagnæs-Hansen3, Niels Uldbjerg1,4, Lars Østergaard1,2, Ole S. Søgaard1,2, Paul W. Denton1,2,5, Martin Tolstrup1,2 1Department of Clinical Medicine, Aarhus University, 2Department of Infectious Diseases, Aarhus University Hospital, 3Department of Biomedicine, Aarhus University, 4Department of Gynecology and Obstetrics, Aarhus University Hospital, 5Department of Biology, University of Nebraska at Omaha JoVE 60723 Immunology and Infection